Flupirtine-induced hepatic failure requiring orthotopic liver transplant

Experimental and Clinical Transplantation

Volumn 9, Issue 4, 2011, Pages 270-272

  Klein, Fritz ^a   Glanemann, Matthias ^a   Rudolph, Birgit ^a   Seehofer, Daniel ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute liver failure; Hepatotoxicity; Katadolon

Indexed keywords

FLUPIRTINE;

ACUTE LIVER FAILURE; ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG PULSE THERAPY; DRUG WITHDRAWAL; EVENING DOSAGE; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTRANSAMINASEMIA; JAUNDICE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; RADICULAR PAIN; TOXIC HEPATITIS; TREATMENT OUTCOME;

AMINOPYRIDINES; ANALGESICS; DRUG-INDUCED LIVER INJURY; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PULSE THERAPY, DRUG; STEROIDS; TREATMENT OUTCOME;

EID: 84860415603     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kornhuber J, Bleich S, Wiltfang J, Maler M, Parsons CG. Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication. J Neural Transm. 1999;106(9-10):857-867.
2. AWD. pharma GmbH: Fachinformation "Katadolon. " 2005.
3. Drug Commission of the German Medical Association. Liver damage induced by Flupirtine.-ADR Database 2007.
4. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376(9736):190-201.
5. Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42(6):1364-1372.
6. Devarbhavi H, Dierkhising R, Kremers WK, Sandeep MS, Karanth D, Adarsh CK. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol. 2010;105(11):2396-2404.
7. Lat I, Foster DR, Erstad B. Drug-induced acute liver failure and gastrointestinal complications. Crit Care Med. 2010;38(suppl 6):S175-S187.
8. Suzuki A, Andrade RJ, Bjornsson E, et al. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work. Drug Saf. 2010;33(6):503-522.
9. Powell-Jackson P, Williams R. Use of flupirtine maleate as an analgesic in patients with liver disease. Br J Clin Pract. 1985;39(2):63-66.
10. Dierkes-Globisch A, Schafer R, Mohr HH. Asymptomatic diclofenacinduced acute hepatitis [in German]. Dtsch Med Wochenschr. 2000;125(25-26):797-800.
11. Huang YS, Su WJ, Huang YH, et al. Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury. J Hepatol. 2007;47(1):128-134.
12. Wigg AJ, Gunson BK, Mutimer DJ. Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12-year period with more than 100 patients. Liver Transpl. 2005;11(1):27-34.